For shyster shrinks, these must be glorious days indeed. Lying drug company lacky, Charles Nemeroff, after getting booted off Emory University campus for lying about the extent of funds he received from prescription drug cartels, gets hired by the University of Miami, and now is being honored (for his dishonor?) in Great Britain. Conflict of interest, literally corruption, has never had it so good before.
The headline in The Independent, Honoured in Britain, the US psychiatrist who took $1.2m from drug companies, doesn’t quite tell the whole story. It wasn’t that he took well over a million dollars from drug companies. There is a law in the USA requiring US doctors in academia to reveal the amount of money they received from prescription drug companies, and scofflaw Dr. Charles Nemeroff lied about this matter to the tune of 1 million smackers and 2 hundred k.
The good news is that, at least, this decision has generated controversy, and there are people in England who challenge it.
The decision by the Institute of Psychiatry at Kings College, in central London, Europe’s largest psychiatric research organization, to invite Professor Charles Nemeroff, an expert in the treatment of depression, has split the psychiatric profession and been attacked by members of the institute itself. Professor Nemeroff, a leading authority on the biological causes of mental illness, is one of the highest profile doctors to have been exposed for concealing large payments from pharmaceutical companies.
He was forced to resign his post at Emory University, Atlanta, in 2008 after an investigation revealed that he had failed to report more than $1.2m of payments from GlaxoSmithKline, despite having signed an undertaking to limit payments to $10,000 a year.
This firing resulted in a subsequent appointment to the University of Miami and a research grant on top of it. What’s it to the University of Miami so long as drug companies are being sued and not institutions of higher education? The crook they took is now being honored as a conquering hero.
In what other field would lawbreaking be considered an advantageous career move? Drug companies are receiving the highest civil suit penalties in history for off-label prescription practices and here, one their pigeons, is being honored for his deceit.
Not everybody is happy with this decision. Some people object to this advancement of the criminal element.
Now a group of UK psychiatrists have written to the Institute of Psychiatry protesting against its decision to invite Professor Nemeroff to give the “inaugural annual lecture for the new Centre for Affective Disorders”, which is due to take place at the institute next Monday.
Knuckle rapping is one thing, promotions, that’s another. This leaves the question open as to which psychiatrist will be the next to turn criminal activities into a strategic career move.
Filed under: Biological Psychiatry, Brain Damage, Conflict of Interest, Education, Ethics, Investigation, Law, Psychiatric Drugs, Violence | Tagged: charles nemeroff, drug cartels, emory university atlanta, emory university campus, prescription drug companies, psychiatric profession |